131 related articles for article (PubMed ID: 8661397)
41. Membrane-interactive phospholipids inhibit HIV type 1-induced cell fusion and surface gp160/gp120 binding to monoclonal antibody.
Krugner-Higby L; Goff D; Edwards T; Iyer N; Neufeld J; Kute T; Morris-Natschke S; Ishaq K; Piantadosi C; Kucera LS
AIDS Res Hum Retroviruses; 1995 Jun; 11(6):705-12. PubMed ID: 7576930
[TBL] [Abstract][Full Text] [Related]
42. Deletion of a single N-linked glycosylation site from the transmembrane envelope protein of human immunodeficiency virus type 1 stops cleavage and transport of gp160 preventing env-mediated fusion.
Dash B; McIntosh A; Barrett W; Daniels R
J Gen Virol; 1994 Jun; 75 ( Pt 6)():1389-97. PubMed ID: 8207403
[TBL] [Abstract][Full Text] [Related]
43. Analysis of the human immunodeficiency virus type 1 envelope protein interaction with the CD4 host cell receptor.
Malvoisin E; Wild F
J Gen Virol; 1994 Apr; 75 ( Pt 4)():839-47. PubMed ID: 8151300
[TBL] [Abstract][Full Text] [Related]
44. Expression and characterization of a functional human immunodeficiency virus envelope glycoprotein in insect cells.
Wells DE; Compans RW
Virology; 1990 Jun; 176(2):575-86. PubMed ID: 2111957
[TBL] [Abstract][Full Text] [Related]
45. Study of the interaction of HIV-1 and HIV-2 envelope glycoproteins with the CD4 receptor and role of N-glycans.
Bahraoui E; Benjouad A; Guetard D; Kolbe H; Gluckman JC; Montagnier L
AIDS Res Hum Retroviruses; 1992 May; 8(5):565-73. PubMed ID: 1515210
[TBL] [Abstract][Full Text] [Related]
46. Intracellular diversion of glycoprotein GP160 of human immunodeficiency virus to lysosomes as a strategy of AIDS gene therapy.
Lin X; Dashti A; Schinazi RF; Tang J
FASEB J; 1993 Aug; 7(11):1070-80. PubMed ID: 8370478
[TBL] [Abstract][Full Text] [Related]
47. HIV-1 envelope glycoproteins induce activation of activated protein-1 in CD4+ T cells.
Chirmule N; Goonewardena H; Pahwa S; Pasieka R; Kalyanaraman VS; Pahwa S
J Biol Chem; 1995 Aug; 270(33):19364-9. PubMed ID: 7642615
[TBL] [Abstract][Full Text] [Related]
48. Correlation between high level gp160 expression and reduced CD4 biosynthesis in clonal derivatives of human immunodeficiency virus type 1-infected U-937 cells.
Geleziunas R; Bour S; Wainberg MA
J Gen Virol; 1994 Apr; 75 ( Pt 4)():857-65. PubMed ID: 8151301
[TBL] [Abstract][Full Text] [Related]
49. Functional roles of the V3 hypervariable region of HIV-1 gp160 in the processing of gp160 and in the formation of syncytia in CD4+ cells.
Travis BM; Dykers TI; Hewgill D; Ledbetter J; Tsu TT; Hu SL; Lewis JB
Virology; 1992 Jan; 186(1):313-7. PubMed ID: 1727607
[TBL] [Abstract][Full Text] [Related]
50. Intracellular interaction of human immunodeficiency virus type 1 (ARV-2) envelope glycoprotein gp160 with CD4 blocks the movement and maturation of CD4 to the plasma membrane.
Jabbar MA; Nayak DP
J Virol; 1990 Dec; 64(12):6297-304. PubMed ID: 2243395
[TBL] [Abstract][Full Text] [Related]
51. The cytoplasmic tail of HIV-1 gp160 contains regions that associate with cellular membranes.
Haffar OK; Dowbenko DJ; Berman PW
Virology; 1991 Jan; 180(1):439-41. PubMed ID: 1984664
[TBL] [Abstract][Full Text] [Related]
52. Human immunodeficiency virus type 1 Vpu protein induces rapid degradation of CD4.
Willey RL; Maldarelli F; Martin MA; Strebel K
J Virol; 1992 Dec; 66(12):7193-200. PubMed ID: 1433512
[TBL] [Abstract][Full Text] [Related]
53. Inhibition of gp160 and CD4 maturation in U937 cells after both defective and productive infections by human immunodeficiency virus type 1.
Bour S; Boulerice F; Wainberg MA
J Virol; 1991 Dec; 65(12):6387-96. PubMed ID: 1942241
[TBL] [Abstract][Full Text] [Related]
54. Temporal expression of HIV-1 envelope proteins in baculovirus-infected insect cells: implications for glycosylation and CD4 binding.
Murphy CI; Lennick M; Lehar SM; Beltz GA; Young E
Genet Anal Tech Appl; 1990 Oct; 7(6):160-71. PubMed ID: 2076345
[TBL] [Abstract][Full Text] [Related]
55. Calcium requirement and inhibitor spectrum for intracellular HIV type 1 gp160 processing in cultured HeLa cells and CD4+ lymphocytes: similarity to those of viral envelope glycoprotein maturase.
Kamoshita K; Shiota M; Sasaki M; Koga Y; Okumura Y; Kido H
J Biochem; 1995 Jun; 117(6):1244-53. PubMed ID: 7490267
[TBL] [Abstract][Full Text] [Related]
56. [Pathological cleavage of human immunodeficiency virus gp160 protein in infected cells as a probable factor for infection becoming chronic].
Veselovskaia TV; Rykova LA; Selimova LM; Zaĭdes VM
Mol Biol (Mosk); 1993; 27(1):211-21. PubMed ID: 8483471
[TBL] [Abstract][Full Text] [Related]
57. Processing and routage of HIV glycoproteins by furin to the cell surface.
Moulard M; Hallenberger S; Garten W; Klenk HD
Virus Res; 1999 Mar; 60(1):55-65. PubMed ID: 10225274
[TBL] [Abstract][Full Text] [Related]
58. Lectin-carbohydrate interactions and infectivity of human immunodeficiency virus type 1 (HIV-1).
Gattegno L; Ramdani A; Jouault T; Saffar L; Gluckman JC
AIDS Res Hum Retroviruses; 1992 Jan; 8(1):27-37. PubMed ID: 1736938
[TBL] [Abstract][Full Text] [Related]
59. Vaccinia virus vectors for study of membrane fusion mediated by human immunodeficiency virus envelope glycoprotein and CD4.
Ashorn P; Berger EA; Moss B
Methods Enzymol; 1993; 221():12-8. PubMed ID: 8361369
[No Abstract] [Full Text] [Related]
60. Mutations within the human immunodeficiency virus type 1 gp160 envelope glycoprotein alter its intracellular transport and processing.
Willey RL; Klimkait T; Frucht DM; Bonifacino JS; Martin MA
Virology; 1991 Sep; 184(1):319-29. PubMed ID: 1871974
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
